HomeGreater Than Icon
Krsnaa Diagnostics LtdGreater Than Icon
Krsnaa Diagnostics Ltd Financials
Company Logo

Krsnaa Diagnostics Ltd Financial Statement

Krsnaa Diagnostics Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue183.33
Operating Expense126.24
Net Profit21.97
Net Profit Margin11.98
Earning Per Share6.80
EBIDTA55.66
Effective Tax Rate8.93

Krsnaa Diagnostics Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual590.02
Operating Expenses Annual443.86
Operating Profit Annual162.96
Interest Annual16.47
Depreciation73.90
Net Profit Annual58.56
Tax Annual13.38

Krsnaa Diagnostics Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning22.13
Cash Flow from Operations24.39
Cash Flow from Investing-128.88
Cash Flow from Financing84.21
Cash Flow at the End1.86

Krsnaa Diagnostics Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)27.62
PBIT Margin (%)14.98
PBT Margin (%)14.07
Net PROFIT Margin (%)9.93
Return On Networth / Equity (%)7.52
Return On Networth /Employed (%)9.79
Return On Assets (%)6.45
Total Debt / Equity (X)0.12
Asset Turnover Ratio (%)0.65

Krsnaa Diagnostics Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual647.16
Total Current Assets Annual422.41
Non Current Assets Annual749.16
Total Shareholders Funds Annual815.24
Total Assets Annual1,171.57

Krsnaa Diagnostics Ltd Earning Calls

EPS (INR)

Expected

6.07

Reported

6.07

Surprise

0.00%

Jun 2024

EPS beaten by 0.00%

Mar 2024

EPS beaten by 0.00%

Dec 2023

EPS beaten by 0.00%

Get Your FAQs Right

As of Nov 5, 2024, Krsnaa Diagnostics Ltd has a market capitalization of 1,985.34 Cr. Value Research classifies it as a Small-Cap company.
Yes, Krsnaa Diagnostics Ltd is debt-free with a debt-to-equity ratio of 0.20.
In FY 2023 , Krsnaa Diagnostics Ltd recorded a total revenue of approximately 590.02 Cr marking a significant milestone in the company's financial performance.
Krsnaa Diagnostics Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.1% and 0.1% annually, respectively..
Krsnaa Diagnostics Ltd's current PE ratio is 33.90.
Krsnaa Diagnostics Ltd's ROCE averaged 11.4% from the FY ending March 2022 to 2024, with a median of 11.1%. It peaked at 14.3% in March 2022, reflecting strong capital efficiency over the period..
Krsnaa Diagnostics Ltd's latest EBIT is Rs. 88.42 Cr, surpassing the average EBIT of Rs. 95.46 Cr over the 5 years..